NEW DELHI (Reuters) Pfizer Inc said on Friday it had withdrawn an application for emergency-use authorisation of its COVID-19 vaccine in India, after failing to meet the drug regulator’s demand for a local safety and immunogenicity study. The decision means the vaccine will not be available for sale in the world’s two most populous countries, … Continue reading An Open Letter to India’s Modi over Globalists & Big Pharma Interests’ as Pfizer drops India vaccine application after regulator seek local trial